Head to Head Review: The Ensign Group (ENSG) and The Competition

The Ensign Group (NASDAQ:ENSG – Get Free Report) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it contrast to its rivals? We will compare The Ensign Group to related companies based on the strength of its institutional ownership, risk, analyst recommendations, dividends, valuation, profitability and earnings.

Dividends

The Ensign Group pays an annual dividend of $0.26 per share and has a dividend yield of 0.1%. The Ensign Group pays out 3.9% of its earnings in the form of a dividend. As a group, “Healthcare Providers & Services” companies pay a dividend yield of 1.5% and pay out 24.9% of their earnings in the form of a dividend. The Ensign Group has raised its dividend for 18 consecutive years.

Institutional & Insider Ownership

96.1% of The Ensign Group shares are held by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are held by institutional investors. 4.0% of The Ensign Group shares are held by insiders. Comparatively, 14.9% of shares of all “Healthcare Providers & Services” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Valuation and Earnings

This table compares The Ensign Group and its rivals gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
The Ensign Group $5.06 billion $343.97 million 26.22
The Ensign Group Competitors $21.13 billion $301.67 million -3.54

The Ensign Group’s rivals have higher revenue, but lower earnings than The Ensign Group. The Ensign Group is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a breakdown of recent recommendations for The Ensign Group and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Ensign Group 0 2 4 0 2.67
The Ensign Group Competitors 1890 7762 13427 841 2.55

The Ensign Group currently has a consensus target price of $226.00, indicating a potential upside of 28.24%. As a group, “Healthcare Providers & Services” companies have a potential upside of 21.80%. Given The Ensign Group’s stronger consensus rating and higher probable upside, equities research analysts plainly believe The Ensign Group is more favorable than its rivals.

Profitability

This table compares The Ensign Group and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
The Ensign Group 7.03% 16.79% 7.07%
The Ensign Group Competitors 1.61% -135.40% -1.32%

Volatility and Risk

The Ensign Group has a beta of 0.66, indicating that its stock price is 34% less volatile than the S&P 500. Comparatively, The Ensign Group’s rivals have a beta of 0.98, indicating that their average stock price is 2% less volatile than the S&P 500.

Summary

The Ensign Group beats its rivals on 10 of the 15 factors compared.

The Ensign Group Company Profile

(Get Free Report)

The Ensign Group, Inc. is a healthcare services company focused on post-acute care and senior living. Through its subsidiaries, it operates skilled nursing and rehabilitation facilities, assisted living communities, and independent living communities. The company also provides home health and hospice services, as well as mobile diagnostics and other ancillary services that support patients and care facilities. Its operations serve communities across multiple U.S. states. Founded in 1999, Ensign has grown from a skilled nursing operator into a broader provider of healthcare and senior services.

Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.